A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
Clinical trial NCT04555096 · TERMINATED
Trial details
- NCT number
- NCT04555096
- Sponsor
- Galera Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2021-05-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.